VJ8-12287-38078
3 vaccinations
3 coded responses
22 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 662 / KS
- Registered
- 2021-05-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-05-03
Registered in v-safe
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort, Dyspnoea — Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Tight chest - difficult breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-04
-
2021-05-05
Survey response — days 1–6 daily, dose 2MedDRA: Chest discomfort, Dyspnoea — Feeling: GoodFree text: Tight chest - difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-06
- 2021-06-13
- 2021-07-30
- 2021-10-29
-
2021-11-26
Dose 3 — Pfizer-BioNTech
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-11-30
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-10
- 2021-12-19
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-02-25
-
2022-05-27
Survey response — 6 months, dose 3MedDRA: Cough, Dyspnoea, Fatigue, Headache, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive for COVID. Cough, headache, fatigue, congestion, shortness of breath.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-31
-
2022-05-31
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2021-11-26 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-05-27 | Successful 2022-05-31 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Tight chest - difficult breathing
Systemic reaction (other): Tight chest - difficulty breathing
Release 11 — 6 months, dose 3
Symptoms: Tested positive for COVID. Cough, headache, fatigue, congestion, shortness of breath.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release